Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Chronic Heart Failure

Free Subscription Articles published in J Cardiol Retrieve available abstracts of 84 articles: HTML format

Single Articles

May 2025
1. EGAMI Y, Kobayashi N, Sugino A, Abe M, et al
   Impact of Sinus Rhythm Maintenance After Repeat Catheter Ablation on Clinical Outcomes in Heart Failure with Preserved Ejection Fraction.
   J Cardiol. 2025 May 20:S0914-5087(25)00127-3. doi: 10.1016/j.jjcc.2025.
   PubMed     Abstract available
   
   
   
2. SHIRAKABE A, Matsushita M, Shigihara S, Nishigoori S, et al
   Age-specific differences of Impella support in Japanese patients: The Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD) registry analysis on outcomes and adverse events.
   J Cardiol. 2025;85:343-351.
   PubMed     Abstract available
   
   
   
3. VOLK MC, Mirzai S, Persits I, Sarnaik KS, et al
   Associations of adipose tissue depots with cardiac resynchronization therapy response and clinical outcomes: A CRT-HF Clinic substudy.
   J Cardiol. 2025;85:421-423.
   PubMed     Abstract available
   
   
   April 2025
4. SHIMOYA Y, Tani Y, Yuasa N, Kagami K, et al
   Pathophysiologic and prognostic relevance of mid-upper arm circumference index in heart failure with preserved ejection fraction.
   J Cardiol. 2025 Apr 28:S0914-5087(25)00107-8. doi: 10.1016/j.jjcc.2025.
   PubMed     Abstract available
   
   
   
5. IBRAHIM M
   Letter to the editor on association between complementary use of Goreisan and heart failure readmission: A nationwide propensity score-matched study.
   J Cardiol. 2025 Apr 24:S0914-5087(25)00104-2. doi: 10.1016/j.jjcc.2025.
   PubMed    
   
   
   
6. SAITO Y, Kagiyama N, Harada T, Kaneko T, et al
   An evidence-based tool for screening for heart failure with preserved ejection fraction in primary care: The BREATH(2) score.
   J Cardiol. 2025 Apr 3:S0914-5087(25)00098-X. doi: 10.1016/j.jjcc.2025.
   PubMed     Abstract available
   
   
   March 2025
7. OKAJIMA T, Ishikawa S, Uemura Y, Ozaki Y, et al
   Efficacy of sodium-glucose cotransporter 2 inhibitors on preventing atrial arrhythmia recurrences after atrial fibrillation ablation in patients with heart failure.
   J Cardiol. 2025 Mar 19:S0914-5087(25)00088-7. doi: 10.1016/j.jjcc.2025.
   PubMed     Abstract available
   
   
   
8. TSUCHIDA K, Tanabe N, Tanaka K, Ozeki K, et al
   Twelve-year trends of hospitalizations and survival of acute decompensated heart failure: Data from a regional tertiary center.
   J Cardiol. 2025 Mar 19:S0914-5087(25)00089-9. doi: 10.1016/j.jjcc.2025.
   PubMed     Abstract available
   
   
   
9. YAMAMOTO A, Nagao M, Nomoto M, Inoue A, et al
   Prediction of cardiac allograft vasculopathy using splenic switch-off on myocardial PET.
   J Cardiol. 2025;85:260-262.
   PubMed     Abstract available
   
   
   February 2025
10. LI M, Zhang J, Hu Y, Zhang Y, et al
    Cognitive impairment in patients with heart failure: Physiopathology, clinical implications, and therapeutic considerations.
    J Cardiol. 2025 Feb 12:S0914-5087(25)00056-5. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
11. HOSODA Y, Goda A, Yanagisawa Y, Miura Y, et al
    Prediction of left ventricular reverse remodeling in patients with heart failure with reduced ejection fraction using cardiopulmonary exercise testing.
    J Cardiol. 2025 Feb 5:S0914-5087(25)00021-8. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
12. SIDDIQI AK, Shahzad M, Kumar A, Ahmed M, et al
    The efficacy of inspiratory muscle training in improving clinical outcomes in heart failure patients: An updated systematic review and Meta-analysis.
    J Cardiol. 2025 Feb 3:S0914-5087(25)00016-4. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
13. HAMAGUCHI K, Sakakura K, Jinnouchi H, Taniguchi Y, et al
    Comparison of clinical outcomes between proximal and non-proximal right coronary artery occlusion in patients with inferior ST-segment elevation myocardial infarction.
    J Cardiol. 2025;85:88-95.
    PubMed     Abstract available
    
    
    January 2025
14. BASILE P, Guaricci AI
    Author's reply to the Letter to the Editor "How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts".
    J Cardiol. 2025 Jan 31:S0914-5087(25)00012-7. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
15. HORIUCHI Y, Matsue Y, Wettersten N, Oishi S, et al
    Racial differences in diuretic therapy, B-type natriuretic peptide values, and prognosis in acute heart failure.
    J Cardiol. 2025 Jan 30:S0914-5087(25)00013-9. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
16. AKAMA Y, Matsue Y, Maeda D, Dotare T, et al
    Prognostic values of proteinuria in patients with acute heart failure.
    J Cardiol. 2025 Jan 28:S0914-5087(25)00010-3. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
17. KATAOKA N, Imamura T
    How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts.
    J Cardiol. 2025 Jan 20:S0914-5087(25)00006-1. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
18. YUASA N, Ubukata S, Takayanagi R, Yamashita E, et al
    Collaboration between dyspnea clinic and primary care physicians to identify heart failure with preserved ejection fraction in the community: Results from the Maebashi City HF project.
    J Cardiol. 2025 Jan 14:S0914-5087(25)00001-2. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
19. PASCOE MA, Kolodziej A, Birks EJ, Vaidya G, et al
    Using electronic medical records to identify patients at risk for underlying cardiac amyloidosis.
    J Cardiol. 2025;85:43-44.
    PubMed     Abstract available
    
    
    December 2024
20. SUZUKI Y, Kaneko H, Okada A, Fujiu K, et al
    BP classification using the 2017 ACC/AHA BP guidelines with risk of cardiovascular events in older individuals.
    J Cardiol. 2024;84:394-403.
    PubMed     Abstract available
    
    
    November 2024
21. RAJAKUMAR HK
    Telemonitoring in heart failure care: Does feasibility equate to clinical benefit?
    J Cardiol. 2024 Nov 26:S0914-5087(24)00219-3. doi: 10.1016/j.jjcc.2024.
    PubMed    
    
    
    
22. RMILAH AA, Abdelhafez M, Balla AK, Ahmad S, et al
    Outcomes of mitral TEER in non-responders to cardiac resynchronization therapy: A systematic review and meta-analysis.
    J Cardiol. 2024;84:317-325.
    PubMed     Abstract available
    
    
    
23. ONODA H, Imamura T, Ueno H, Oshima A, et al
    Paradoxical prognostic impact of severe aortic stenosis following trans-catheter aortic valve implantation.
    J Cardiol. 2024;84:311-316.
    PubMed     Abstract available
    
    
    October 2024
24. KOMURO J, Kaneko H, Suzuki Y, Okada A, et al
    Unawareness of being prescribed medications for diabetes and incident cardiovascular disease.
    J Cardiol. 2024;84:294-299.
    PubMed     Abstract available
    
    
    
25. MIYAKE M, Izumi C, Watanabe H, Ozasa N, et al
    Prognostic value of E/e' ratio and its change over time in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction in the reperfusion era.
    J Cardiol. 2024;84:253-259.
    PubMed     Abstract available
    
    
    September 2024
26. ISOGAI T, Morita K, Okada A, Michihata N, et al
    Association between complementary use of Goreisan (a Japanese herbal Kampo medicine) and heart failure readmission: A Nationwide propensity score-matched study.
    J Cardiol. 2024 Sep 26:S0914-5087(24)00182-5. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
27. SUETA D, Araki S, Usuku H, Fujisaki T, et al
    Clinical outcomes of patients from older community hospitalized for heart failure in guideline-directed medical therapy era: Insights from the COMPASS-HF registry.
    J Cardiol. 2024 Sep 17:S0914-5087(24)00178-3. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
28. TSUTSUI H, Momomura SI, Saito Y, Ito H, et al
    Incidence and risk factors of hypotension-related adverse events among Japanese patients with heart failure receiving sacubitril/valsartan or enalapril: Results from the PARALLEL-HF study.
    J Cardiol. 2024 Sep 14:S0914-5087(24)00174-6. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
29. BASILE P, Monitillo F, Santoro D, Falco G, et al
    Impact on ventricular arrhythmic burden of SGLT2 inhibitors in patients with chronic heart failure evaluated with cardiac implantable electronic device monitoring.
    J Cardiol. 2024 Sep 13:S0914-5087(24)00177-1. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
30. MIYAZAKI Y, Ishibashi K, Ueda N, Oka S, et al
    Evaluation of synchronized left ventricular pacing rate over biventricular pacing in cardiac resynchronization therapy.
    J Cardiol. 2024;84:165-169.
    PubMed     Abstract available
    
    
    August 2024
31. MISUMI K, Matsue Y, Nogi K, Fujimoto Y, et al
    Usefulness of hypochloremia at the time of discharge to predict prognosis in patients with chronic heart failure after hospitalization.
    J Cardiol. 2024 Aug 30:S0914-5087(24)00171-0. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
32. HASHEM A, Khalouf A, Mohamed MS, Adra S, et al
    Early vs. Late Transcatheter Aortic Valve Replacement in Acute Heart Failure Hospitalizations: A Comparative Nationwide Analysis.
    J Cardiol. 2024 Aug 16:S0914-5087(24)00159-X. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
33. MATSUMOTO S, McMurray JJV, Nasu T, Ishii S, et al
    Relevant adverse events and drug discontinuation of sacubitril/valsartan in a real-world Japanese cohort: REVIEW-HF registry.
    J Cardiol. 2024;84:133-140.
    PubMed     Abstract available
    
    
    
34. MATSUSHITA H, Saku K, Nishikawa T, Unoki T, et al
    Impact of right ventricular and pulmonary vascular characteristics on Impella hemodynamic support in biventricular heart failure: A simulation study.
    J Cardiol. 2024 Aug 1:S0914-5087(24)00145-X. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    July 2024
35. INOUE K, Smiseth OA
    Left atrium as key player and essential biomarker in heart failure.
    J Cardiol. 2024 Jul 29:S0914-5087(24)00135-7. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
36. 
    Urinary sodium excretion for loop diuretic response in acute heart failure.
    J Cardiol. 2024 Jul 5:S0914-5087(24)00129-1. doi: 10.1016/j.jjcc.2024.
    PubMed    
    
    
    June 2024
37. OKADA T, Takagi W, Miyoshi T, Oka A, et al
    Efficacy and safety of intravenous versus oral tolvaptan in the acute phase of acute decompensated heart failure.
    J Cardiol. 2024 Jun 23:S0914-5087(24)00125-4. doi: 10.1016/j.jjcc.2024.
    PubMed    
    
    
    
38. NODA T, Kamiya K, Hamazaki N, Nozaki K, et al
    Effect of change in hepato-renal function and cardiac rehabilitation on mortality in patients with heart failure.
    J Cardiol. 2024 Jun 23:S0914-5087(24)00123-0. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
39. HORIUCHI Y, Wettersten N
    Treatment strategies for diuretic resistance in patients with heart failure.
    J Cardiol. 2024 Jun 22:S0914-5087(24)00122-9. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
40. ITO H, Fujimoto N, Mori H, Kirii Y, et al
    Unveiling the new era of heart failure management using mobile health: A pilot study of "heart sign" focusing on user experience and quality of life.
    J Cardiol. 2024 Jun 11:S0914-5087(24)00103-5. doi: 10.1016/j.jjcc.2024.
    PubMed    
    
    
    
41. SHIBATA T, Mizuno A, Ohmori T, Oishi S, et al
    Public awareness of palliative care for heart failure in Japan: A cross-sectional study.
    J Cardiol. 2024 Jun 3:S0914-5087(24)00101-1. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
42. SHIINA Y, Nagao M, Itatani K, Shimada E, et al
    4D flow MRI-derived energy loss and RV workload in adults with tetralogy of Fallot.
    J Cardiol. 2024;83:382-389.
    PubMed     Abstract available
    
    
    May 2024
43. VLACHAKIS PK, Tsiachris D, Doundoulakis I, Tsioufis P, et al
    Therapeutic inertia in rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study.
    J Cardiol. 2024;83:313-317.
    PubMed     Abstract available
    
    
    
44. KAGIYAMA N, Kasai T, Murata N, Yamakawa N, et al
    Feasibility of self-measurement Telemonitoring using a handheld heart sound recorder in patients with heart failure - SELPH multicenter pilot study.
    J Cardiol. 2024 May 1:S0914-5087(24)00082-0. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    April 2024
45. BUTTER L, Haase-Fielitz A, Zanker M, Becher G, et al
    Cluster analysis of volatile organic compounds - a pilot study in patients with severe acute decompensated heart failure.
    J Cardiol. 2024 Apr 13:S0914-5087(24)00062-5. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
46. MAKHOUL GW, Mustafa A, Wei C, Ling J, et al
    Heart failure - An unexplored risk factor for infective endocarditis after pacemaker implantation.
    J Cardiol. 2024 Apr 5:S0914-5087(24)00061-3. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
47. SAITO S, Okubo S, Matsuoka T, Hirota S, et al
    Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
    J Cardiol. 2024;83:228-235.
    PubMed     Abstract available
    
    
    March 2024
48. OHIRA T, Eguchi E, Hayashi F, Kinuta M, et al
    Epidemiology of cardiovascular disease in Japan: An overview study.
    J Cardiol. 2024;83:191-200.
    PubMed     Abstract available
    
    
    
49. ONODA H, Imamura T, Ueno H, Oshima A, et al
    Prognostic impact of elevated erythropoietin levels in patients with severe aortic stenosis receiving trans-catheter aortic valve implantation.
    J Cardiol. 2024;83:149-154.
    PubMed     Abstract available
    
    
    February 2024
50. SUGAWARA M, Kondo Y, Ryuzaki S, Yoshino Y, et al
    Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy.
    J Cardiol. 2024 Feb 19:S0914-5087(24)00024-8. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
51. YAKU H, Fudim M, Shah SJ
    Role of splanchnic circulation in the pathogenesis of heart failure: State-of-the-art review.
    J Cardiol. 2024 Feb 16:S0914-5087(24)00022-4. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
52. SHIBATA T, Matsumoto S, Muramoto T, Matsukawa M, et al
    Comparison of the treatment status of patients with acute heart failure before and during the COVID-19 pandemic - Observational cohort study using Japanese administrative data.
    J Cardiol. 2024 Feb 2:S0914-5087(24)00011-X. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    December 2023
53. SATO K, Kamiya K, Hamazaki N, Nozaki K, et al
    Association of sarcopenia defined by different skeletal muscle mass measurements with prognosis and quality of life in older patients with heart failure.
    J Cardiol. 2023 Dec 20:S0914-5087(23)00305-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
54. TOMSIC A, Meucci MC, de Jong AR, Braun J, et al
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2023 Dec 14:S0914-5087(23)00295-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    November 2023
55. HEIDENREICH P
    Heart failure management guidelines: New recommendations and implementation.
    J Cardiol. 2023 Nov 8:S0914-5087(23)00271-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    October 2023
56. UCHIYAMA S, Toki M, Kitai T, Yoshioka K, et al
    Dynamic changes in echocardiographic parameters in acute decompensated heart failure: REALITY-ECHO.
    J Cardiol. 2023 Oct 24:S0914-5087(23)00268-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
57. POL T, Karlstrom P, Lund LH
    Heart failure registries - Future directions.
    J Cardiol. 2023 Oct 14:S0914-5087(23)00257-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
58. SI J, Ding Z, Hu Y, Zhang X, et al
    Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
    J Cardiol. 2023 Oct 5:S0914-5087(23)00242-3. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
59. OKAMURA M, Kataoka Y, Taito S, Fujiwara T, et al
    Early mobilization for acute heart failure: A scoping and a systematic review.
    J Cardiol. 2023 Oct 3:S0914-5087(23)00239-3. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    September 2023
60. SEO M, Watanabe T, Yamada T, Morita T, et al
    The clinical relevance of mild cognitive impairment in acute heart failure: A comparison with cognitive impairment.
    J Cardiol. 2023 Sep 6:S0914-5087(23)00222-8. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
61. MATSUDA H, Kuragaichi T, Sato Y
    Investigating the seasonal variation of heart failure hospitalizations and in-hospital mortality risks in Japan using a nationwide database.
    J Cardiol. 2023 Sep 2:S0914-5087(23)00219-8. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    August 2023
62. HORIBE H, Ando K, Maekawa Y, Narisawa M, et al
    The association of serum adiponectin level with activities of daily living in hospitalized elderly patients with heart failure.
    J Cardiol. 2023 Aug 15:S0914-5087(23)00202-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
63. HARRISON NE, Ehrman R, Collins S, Desai AA, et al
    The prognostic value of improving congestion on lung ultrasound during treatment for acute heart failure differs based on patient characteristics at admission.
    J Cardiol. 2023 Aug 12:S0914-5087(23)00190-9. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
64. ICHIHARA YK, Kohsaka S, Kisanuki M, Sandhu ATS, et al
    Implementation of evidence-based heart failure management: Regional variations between Japan and the USA.
    J Cardiol. 2023 Aug 3:S0914-5087(23)00185-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
65. KLARSKOV VR, Ladefoged BT, Pedersen ALD, Hartig-Andreasen C, et al
    Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy.
    J Cardiol. 2023;82:122-127.
    PubMed     Abstract available
    
    
    July 2023
66. YUASA N, Obokata M, Harada T, Kagami K, et al
    Characterization and Prognostic Importance of Chronotropic Incompetence in Heart Failure with Preserved Ejection Fraction.
    J Cardiol. 2023 Jul 5:S0914-5087(23)00159-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
67. FERREIRA JP, Zannad F, Kiernan MS, Konstam MA, et al
    High- versus low-dose losartan and uric acid: An analysis from HEAAL.
    J Cardiol. 2023;82:57-61.
    PubMed     Abstract available
    
    
    
68. UGATA Y, Hayashi T, Yamamoto S, Fujita H, et al
    Impact of Q wave in synthesized V7-9 lead on long-term outcomes after cardiac resynchronization therapy.
    J Cardiol. 2023;82:51-56.
    PubMed     Abstract available
    
    
    
69. MATSUURA K, Kumamaru H, Kohsaka S, Kanda T, et al
    Impact of concomitant mitral regurgitation during transcatheter aortic valve replacement on 1-year survival outcomes.
    J Cardiol. 2023;82:16-21.
    PubMed     Abstract available
    
    
    
70. NAKAGAWA S, Takahama H, Hoshino K, Yanagi Y, et al
    Prevalence and predictive factors for clinical outcomes of isolated functional tricuspid regurgitation.
    J Cardiol. 2023;82:8-15.
    PubMed     Abstract available
    
    
    June 2023
71. BHATIA K, Sabharwal B, Gupta K, Lopez PD, et al
    Clinical outcomes of intravenous Iron therapy in patients with heart failure and Iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials.
    J Cardiol. 2023 Jun 26:S0914-5087(23)00157-0. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
72. GUDENKAUF B, Shaya G, Mukherjee M, Michos ED, et al
    Insulin resistance is associated with subclinical myocardial dysfunction and reduced functional capacity in heart failure with preserved ejection fraction.
    J Cardiol. 2023 Jun 24:S0914-5087(23)00153-3. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
73. HUANG HT, Ko SL, Wang CY, Lo HC, et al
    Risk stratification for worsening renal function and renal decline in heart failure patients with reduced ejection fraction after sacubitril/valsartan treatment.
    J Cardiol. 2023 Jun 7:S0914-5087(23)00129-6. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    May 2023
74. NOGI K, Yamamoto R, Ueda T, Nogi M, et al
    Derivation and validation of a clinical predictive model of NT-proBNP >/=125 pg/mL to detect pre-heart failure.
    J Cardiol. 2023 May 27:S0914-5087(23)00126-0. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
75. KATAOKA N, Imamura T
    Prognostic impact of xanthine oxidoreductase activity in patients with heart failure and atrial fibrillation.
    J Cardiol. 2023 May 24:S0914-5087(23)00115-6. doi: 10.1016/j.jjcc.2023.
    PubMed    
    
    
    
76. TOGASHI I, Sato T
    Conduction system pacing: Current status and prospects.
    J Cardiol. 2023;81:413-419.
    PubMed     Abstract available
    
    
    
77. SHIBASAKI I, Otani N, Saito S, Ogawa H, et al
    Overview of mechanical circulatory support for the management of post-myocardial infarction ventricular septal rupture.
    J Cardiol. 2023;81:491-497.
    PubMed     Abstract available
    
    
    April 2023
78. TAMAKI Y, Iwano H, Murayama M, Ishizaka S, et al
    Application of an echocardiographic scoring system of left ventricular filling pressure to diagnose acute heart failure in patients complaining dyspnea.
    J Cardiol. 2023 Apr 28:S0914-5087(23)00100-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
79. SEGEV A, Maor E, Goldenfeld M, Itelman E, et al
    Atrial fibrillation in young hospitalized patients: clinical characteristics, predictors of new onset, and outcomes.
    J Cardiol. 2023 Apr 26:S0914-5087(23)00096-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
80. JOKI Y, Konishi H, Takasu K, Minamino T, et al
    Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice.
    J Cardiol. 2023;81:347-355.
    PubMed     Abstract available
    
    
    
81. SHINKAWA T, Ichihara Y, Saito S, Ishido M, et al
    Ventricular assist device for end-stage adult congenital heart disease patients: Current status.
    J Cardiol. 2023;81:378-384.
    PubMed     Abstract available
    
    
    March 2023
82. KINOSHITA M, Saito M, Inoue K, Nakagawa H, et al
    Role of the right ventricular contractile reserve during low-load exercise in predicting heart failure readmission.
    J Cardiol. 2023 Mar 8:S0914-5087(23)00049-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    February 2023
83. MISUMI K, Matsue Y, Nogi K, Fujimoto Y, et al
    Derivation and validation of a machine learning-based risk prediction model in patients with acute heart failure.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00045-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
84. TSUTSUI H, Sakamaki H, Momomura SI, Sakata Y, et al
    Cost-effectiveness analysis of Empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-reduced trial.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00046-1. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.